S-nitrosylation of Cdk5 Potential implications in amyloid-β-related neurotoxicity in Alzheimer disease

被引:35
|
作者
Qu, Jing [1 ]
Nakamura, Tomohiro [1 ]
Holland, Emily A. [1 ]
McKercher, Scott R. [1 ]
Lipton, Stuart A. [1 ]
机构
[1] Sanford Burnham Med Res Inst, Del E Webb Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA USA
关键词
nitrosative stress; cyclin-dependent kinase 5; nitric oxide; neuronal NO synthase; transnitrosylation; CYCLIN-DEPENDENT KINASE-5; DOMINANT OPTIC ATROPHY; NITRIC-OXIDE SYNTHASE; MITOCHONDRIAL FISSION; PARKINSONS-DISEASE; P25/CYCLIN-DEPENDENT KINASE-5; OXIDATIVE STRESS; NMDA RECEPTORS; TAU-PROTEIN; MOUSE MODEL;
D O I
10.4161/pri.21250
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aberrant activation of Cdk5 has been implicated in the process of neurodegenerative diseases such as Alzheimer disease (AD). We recently reported that S-nitrosylation of Cdk5 (forming SNO-Cdk5) at specific cysteine residues results in excessive activation of Cdk5, contributing to mitochondrial dysfunction, synaptic damage and neuronal cell death in models of AD. Furthermore, SNO-Cdk5 acts as a nascent S-nitrosylase, transnitrosylating the mitochondrial fission protein Drp1 and enhancing excessive mitochondrial fission in dendritic spines. However, a molecular mechanism that leads to the formation of SNO-Cdk5 in neuronal cells remained obscure. Here, we demonstrate that neuronal nitric oxide synthase (NOS1) interacts with Cdk5 and that the close proximity of the two proteins facilitates the formation of SNO-Cdk5. Interestingly, as a negative feedback mechanism, Cdk5 phosphorylates and suppresses NOS1 activity. Thus, together with our previous report, these findings delineate an S-nitrosylation pathway wherein Cdk5/NOS1 interaction enhances SNO-Cdk5 formation, mediating mitochondrial dysfunction and synaptic loss during the etiology of AD.
引用
收藏
页码:364 / 370
页数:7
相关论文
共 50 条
  • [1] S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by β-amyloid peptide
    Qu, Jing
    Nakamura, Tomohiro
    Cao, Gang
    Holland, Emily A.
    McKercher, Scott R.
    Lipton, Stuart A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (34) : 14330 - 14335
  • [2] Silencing of CDK5 as potential therapy for Alzheimer's disease
    Lopez-Tobon, Alejandro
    Fredy Castro-Alvarez, John
    Piedrahita, Diego
    Boudreau, Ryan L.
    Carlos Gallego-Gomez, Juan
    Patricia Cardona-Gomez, Gloria
    REVIEWS IN THE NEUROSCIENCES, 2011, 22 (02) : 143 - 152
  • [3] S-Nitrosylation in Alzheimer's disease
    Zhao, Qing-Fei
    Yu, Jin-Tai
    Tan, Lan
    MOLECULAR NEUROBIOLOGY, 2015, 51 (01) : 268 - 280
  • [4] Role of Cdk5 in Amyloid-beta Pathology of Alzheimer's Disease
    Lu, Tao-Tao
    Wan, Chengqun
    Yang, Wenming
    Cai, Zhiyou
    CURRENT ALZHEIMER RESEARCH, 2019, 16 (13) : 1206 - 1215
  • [5] S-Nitrosylation in Alzheimer's disease
    Qing-Fei Zhao
    Jin-Tai Yu
    Lan Tan
    Molecular Neurobiology, 2015, 51 : 268 - 280
  • [6] The Role of Cdk5 in Alzheimer's Disease
    Liu, Shu-Lei
    Wang, Chong
    Jiang, Teng
    Tan, Lan
    Xing, Ang
    Yu, Jin-Tai
    MOLECULAR NEUROBIOLOGY, 2016, 53 (07) : 4328 - 4342
  • [7] The Role of Cdk5 in Alzheimer’s Disease
    Shu-Lei Liu
    Chong Wang
    Teng Jiang
    Lan Tan
    Ang Xing
    Jin-Tai Yu
    Molecular Neurobiology, 2016, 53 : 4328 - 4342
  • [8] S-Nitrosylation of ApoE in Alzheimer's Disease
    Abrams, Alexander J.
    Farooq, Amjad
    Wang, Gaofeng
    BIOCHEMISTRY, 2011, 50 (17) : 3405 - 3407
  • [9] Embelin Mitigates Amyloid-β-Induced Neurotoxicity and Cognitive Impairment in Rats: Potential Therapeutic Implications for Alzheimer's Disease
    Arora, Rimpi
    Deshmukh, Rahul
    MOLECULAR NEUROBIOLOGY, 2025, 62 (02) : 1577 - 1590
  • [10] Role of cdk5 in the pathogenesis of Alzheimer's disease
    Lau, LF
    Ahlijanian, MK
    NEUROSIGNALS, 2003, 12 (4-5) : 209 - 214